2026 NPPES data Oncology Clinical Nurse Specialist NPI 1619164589 CNS
Verify on CMS →

DEBRA WINKELJOHN, CNS

Oncology Clinical Nurse Specialist in ALBUQUERQUE, New Mexico. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
606
Medicare Part D claims · 241 beneficiaries · Oncology Clinical Nurse Specialist avg: 435
Generic prescribing
86%
generic claims · 14% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
85.2794/100
▲ 2 pts above national avg 83.1 · [object Object]
Industry payments
$50.11
2 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

DEBRA WINKELJOHN, CNS reported a CMS MIPS final score of 85.2794/100 — above the 83.1 national average — and filed 606 Medicare Part D claims in 2023.

85.2794/100
MIPS score · +2 vs avg
606
Part D claims, 2023
86%
generic prescribing
$50.11
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

DEBRA WINKELJOHN, CNS's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

85 49th percentile higher than 49% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

What does the federal data show about DEBRA WINKELJOHN, CNS?

High performer (top quartile)

NPI registry status

Active

Issued 09/25/2007

NPI 1619164589

Primary specialty

Oncology Clinical Nurse Specialist

Rare

209 US NPIs in this specialty

Medicare Part D claims

606 39% vs specialty avg

2023 prescription claims

Specialty avg: 435

MIPS final score

85.2794/100 2.179400000000001% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in New Mexico

How Oncology Clinical Nurse Specialist compares to other specialties among New Mexico providers

New Mexico providers

Oncology Clinical Nurse Specialist share within New Mexico

1. Oncology Clinical Nurse Specialist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Oncology Clinical Nurse Specialist share within New Mexico

Medicare quality performance — MIPS

DEBRA WINKELJOHN, CNS's 2023 MIPS final score plotted against the Oncology Clinical Nurse Specialist national average

High performer (top quartile)
MIPS Final Score
85.2794/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Oncology Clinical Nurse Specialist) — 85.2794/100 vs national avg 83.1

0%100%National avg83%85.3%
MIPS final score (Oncology Clinical Nurse Specialist) — 85.2794/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

DEBRA WINKELJOHN, CNS appears in the CMS NPPES registry as a Oncology Clinical Nurse Specialist provider holding CNS credentials at 4901 LANG AVE NE, ALBUQUERQUE, NM, 87109, with a listed phone of (505) 842-8171. NPI 1619164589 was issued on 09/25/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what WINKELJOHN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 606 prescription claims written by this provider, covering 241 Medicare beneficiaries and totaling roughly $571K in drug spend, split 14% brand-name and 86% generic by claim count, with an opioid prescribing rate of 13.7%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 85.2794/100 for the 2023 performance year (Quality 79.7481, Cost 76.1833), compared with the national average of 83.1.

Oncology Clinical Nurse Specialist is a narrow specialty nationwide, with 209 enrolled providers across 38 states and an average of 435 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

4901 LANG AVE NE
ALBUQUERQUE, NM 87109

Provider Details

NPI 1619164589
Specialty Oncology Clinical Nurse Specialist
Credentials CNS
Gender Female
NPI Issued 09/25/2007

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

85.2794
Final Score
Avg: 83.1
79.7481
Quality
76.1833
Cost
94
Promoting Interoperability

Reporting: Group practice

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for DEBRA WINKELJOHN, CNS. Source: openpaymentsdata.cms.gov.

Total received

$50

Largest payer

GENZYME CORPORATION

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

DEBRA WINKELJOHN, CNS — brand share 14.0%
Specialty average (est.)

14% brand-name claims vs 86% generic, on 606 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

606
Total Claims
$571K
Total Drug Cost
241
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
838
Total Day Supply
21,414
Brand vs Generic
14% brand / 86% generic
Brand Drug Cost
$509K
Generic Drug Cost
$62K
Opioid Claims
83 (13.7% rate)
Antibiotic Claims
37

Patient Demographics

Average Patient Age
72.7 years
Avg HCC Risk Score
2.25
Gender Split
68% female / 32% male
Age Distribution
<65: 28, 65-74: 124, 75-84: 66, 85+: 23

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What DEBRA WINKELJOHN, CNS prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Venlafaxine Hcl Er
Venlafaxine Hcl
31
Anastrozole
26
Letrozole
26
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
24
Oxycodone Hcl
24
Gabapentin
21
Levothyroxine Sodium
20
Doxycycline Hyclate
15
Dexamethasone
14
Abiraterone Acetate
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Oncology Clinical Nurse Specialist Overview

How DEBRA WINKELJOHN, CNS fits within the Oncology Clinical Nurse Specialist landscape nationally.

209
Oncology Clinical Nurse Specialist Providers in US
38
States with Oncology Clinical Nurse Specialist
435
Avg Claims per Provider

DEBRA WINKELJOHN, CNS's 606 claims are above the specialty average of 435.

Nearby Oncology Clinical Nurse Specialist Providers in New Mexico

Other clinicians with the same primary specialty enrolled in New Mexico, drawn from the same CMS NPPES roster as WINKELJOHN.

Compare Oncology Clinical Nurse Specialist nationally: see state-by-state distribution →

Frequently Asked Questions

What is DEBRA WINKELJOHN, CNS's specialty?
DEBRA WINKELJOHN, CNS specializes in Oncology Clinical Nurse Specialist and practices in ALBUQUERQUE, New Mexico. Credentials: CNS.
How much does DEBRA WINKELJOHN, CNS prescribe under Medicare Part D?
In 2023, DEBRA WINKELJOHN, CNS wrote 606 Medicare Part D claims totaling $571K in drug costs for 241 beneficiaries.
What is DEBRA WINKELJOHN, CNS's Medicare quality score?
DEBRA WINKELJOHN, CNS has a CMS MIPS Final Score of 85.2794/100 (Quality: 79.7481, Cost: 76.1833). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is DEBRA WINKELJOHN, CNS located?
DEBRA WINKELJOHN, CNS is located at 4901 LANG AVE NE, ALBUQUERQUE, NM, 87109. Phone: (505) 842-8171.
What is DEBRA WINKELJOHN, CNS's NPI number?
DEBRA WINKELJOHN, CNS's National Provider Identifier (NPI) is 1619164589, issued on 09/25/2007.
Does DEBRA WINKELJOHN, CNS prescribe more brand-name or generic drugs?
DEBRA WINKELJOHN, CNS's prescribing is 14% brand-name and 86% generic drugs by claim count, with $509K in brand drug costs.
Does DEBRA WINKELJOHN, CNS prescribe opioids?
Yes, DEBRA WINKELJOHN, CNS had 83 opioid claims in 2023 with an opioid prescribing rate of 13.7%.
How many Oncology Clinical Nurse Specialist providers are there in the US?
There are 209 Oncology Clinical Nurse Specialist providers across 38 states in the US. The average Oncology Clinical Nurse Specialist provider writes 435 Medicare Part D claims per year.
What drugs does DEBRA WINKELJOHN, CNS prescribe most often?
Based on 2023 Medicare Part D data, DEBRA WINKELJOHN, CNS's most frequently prescribed drugs include Venlafaxine Hcl Er, Anastrozole, Letrozole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does DEBRA WINKELJOHN, CNS accept Medicare?
DEBRA WINKELJOHN, CNS appears in CMS Medicare data with 606 Part D claims and 241 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify DEBRA WINKELJOHN, CNS's credentials?
DEBRA WINKELJOHN, CNS's NPI is 1619164589 with credentials CNS. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology